IP Library Granted Patent US 7,670,778
Granted Patent B2
US 7,670,778 · App. 11/973,006 · Granted Mar 2, 2010

Tumor suppressor pathway in

Assignee: Massachusetts Institute of Technolgoy
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,778
App. No.
11/973,006
Granted
Mar 2, 2010
Kind
B2
Abstract

The invention provides novel lin-8, lin-56, and lin-61 genes and polypeptides involved in cell fate determination and in cell proliferation. In addition, the invention includes mutants of these three genes, as well as methods for utilizing these genes, and their encoded polypeptides, in diagnosing and treating abnormal cell proliferation.

Claims (11)

1. A method of identifying a candidate molecule for decreasing cell proliferation, wherein said method comprises:

(i) contacting a cell expressing a human homolog of a C. elegans lin-61 nucleic acid with said candidate molecule, wherein said human homolog encodes an amino acid sequence at least 99% identical to the amino acid sequence of SEQ ID NO: 68;

(ii) measuring the level of expression of said human homolog in said contacted cell;

(iii) comparing the level of expression of said human homolog in said contacted cell and a control cell, wherein said control cell is cultured in the absence of the candidate molecule; wherein an increase in said level of expression identifies a candidate molecule for decreasing cell proliferation.

2. The method of claim 1 , wherein the human homolog encodes the amino acid sequence of SEQ ID NO: 68.

3. The method of claim 1 , wherein said measuring is performed by hybridization.

4. The method of claim 1 , wherein said cell expressing said human homolog is a mammalian cell.

5. The method of claim 4 , wherein said mammalian cell is a human cell.

6. The method of claim 1 , wherein said cell is a transformed cell.

7. The method of claim 1 , wherein said candidate molecule is a peptide molecule.

8. The method of claim 7 , wherein said peptide molecule is present in a cell extract.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 9, 2011
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027357/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2008
From: HORVITZ, H. ROBERT; DAVISON, EWA M.; LU, XIAOWEI
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 021011/0364 →
Continuity (4)
Continuation 1083989600 · May 6, 2004
Continuation 0987252300 · Jun 1, 2001
Provisional Application 6020880200 · Jun 2, 2000
Related Publication 20080213777A1 · Sep 4, 2008